Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Sequencing Reagents Market, by Type
1.4.2 Europe Sequencing Reagents Market, by Technology
1.4.3 Europe Sequencing Reagents Market, by Application
1.4.4 Europe Sequencing Reagents Market, by End Use
1.4.5 Europe Sequencing Reagents Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2023, Feb – 2024, Apr) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Sequencing Reagents Market by Type
5.1 Europe Sequencing Kits Market by Country
5.2 Europe Library Kits Market by Country
5.3 Europe Control Kits Market by Country
5.4 Europe Template Kits Market by Country
5.5 Europe Other Type Market by Country
Chapter 6. Europe Sequencing Reagents Market by Technology
6.1 Europe Next-Generation Sequencing Market by Country
6.2 Europe Third Generation Sequencing Market by Country
6.3 Europe Sanger Sequencing Market by Country
Chapter 7. Europe Sequencing Reagents Market by Application
7.1 Europe Oncology Market by Country
7.2 Europe Reproductive Health Market by Country
7.3 Europe Clinical Investigation Market by Country
7.4 Europe Agrigenomics & Forensics Market by Country
7.5 Europe Consumer Genomics Market by Country
7.6 Europe Other Application Market by Country
Chapter 8. Europe Sequencing Reagents Market by End Use
8.1 Europe Academic Research Market by Country
8.2 Europe Clinical Research Market by Country
8.3 Europe Hospitals & Clinics Market by Country
8.4 Europe Pharmaceutical & Biotechnology Companies Market by Country
8.5 Europe Other End Use Market by Country
Chapter 9. Europe Sequencing Reagents Market by Country
9.1 Germany Sequencing Reagents Market
9.1.1 Germany Sequencing Reagents Market by Type
9.1.2 Germany Sequencing Reagents Market by Technology
9.1.3 Germany Sequencing Reagents Market by Application
9.1.4 Germany Sequencing Reagents Market by End Use
9.2 UK Sequencing Reagents Market
9.2.1 UK Sequencing Reagents Market by Type
9.2.2 UK Sequencing Reagents Market by Technology
9.2.3 UK Sequencing Reagents Market by Application
9.2.4 UK Sequencing Reagents Market by End Use
9.3 France Sequencing Reagents Market
9.3.1 France Sequencing Reagents Market by Type
9.3.2 France Sequencing Reagents Market by Technology
9.3.3 France Sequencing Reagents Market by Application
9.3.4 France Sequencing Reagents Market by End Use
9.4 Russia Sequencing Reagents Market
9.4.1 Russia Sequencing Reagents Market by Type
9.4.2 Russia Sequencing Reagents Market by Technology
9.4.3 Russia Sequencing Reagents Market by Application
9.4.4 Russia Sequencing Reagents Market by End Use
9.5 Spain Sequencing Reagents Market
9.5.1 Spain Sequencing Reagents Market by Type
9.5.2 Spain Sequencing Reagents Market by Technology
9.5.3 Spain Sequencing Reagents Market by Application
9.5.4 Spain Sequencing Reagents Market by End Use
9.6 Italy Sequencing Reagents Market
9.6.1 Italy Sequencing Reagents Market by Type
9.6.2 Italy Sequencing Reagents Market by Technology
9.6.3 Italy Sequencing Reagents Market by Application
9.6.4 Italy Sequencing Reagents Market by End Use
9.7 Rest of Europe Sequencing Reagents Market
9.7.1 Rest of Europe Sequencing Reagents Market by Type
9.7.2 Rest of Europe Sequencing Reagents Market by Technology
9.7.3 Rest of Europe Sequencing Reagents Market by Application
9.7.4 Rest of Europe Sequencing Reagents Market by End Use
Chapter 10. Company Profiles
10.1 Agilent Technologies, Inc.
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Danaher Corporation (Beckman Coulter, Inc.)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 SWOT Analysis
10.4 Abbott Laboratories
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.6 SWOT Analysis
10.5 Bio-Rad laboratories, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.5.5.2 Product Launches and Product Expansions:
10.5.6 SWOT Analysis
10.6 Quest Diagnostics Incorporated
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental Analysis
10.6.4 SWOT Analysis
10.7 Revvity, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent strategies and developments:
10.7.5.1 Partnerships, Collaborations, and Agreements:
10.7.6 SWOT Analysis
10.8 Eurofins Scientific SE
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Regional Analysis
10.8.4 Recent strategies and developments:
10.8.4.1 Partnerships, Collaborations, and Agreements:
10.8.5 SWOT Analysis
10.9 Hologic, Inc.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expenses
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisition and Mergers:
10.9.6 SWOT Analysis
10.10. Illumina, Inc.
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Segment and Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Product Launches and Product Expansions:3
10.10.6 SWOT Analysis
Unique Offerings 